The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.

Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly tripling in price.

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...

The Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

Progressive and incurable, Alzheimer’s disease affects an estimated 6.7 million U.S. adults at least 65 years old, according ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

Medicare is big business. It changes a little or a lot every year, and millions have strong opinions about it.

President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics ...